The recent ruling by the Court of Justice of the European Union that DNA patents are not infringed if the DNA in question is not functional, may make it harder for companies to enforce such patents
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.